Insights: News Releases Kilpatrick Townsend Hosts ACC San Diego’s First 2016 Technology & Licensing Roundtable
SAN DIEGO (February 18) – On February 11, Kilpatrick Townsend & Stockton hosted the Association of Corporate Counsel’s (ACC), San Diego Chapter, First Technology & Licensing Roundtable in 2016. Over 25 in-house legal counsel from the San Diego area attended the event.
Kilpatrick Townsend Partner Kandace Watson and George Ng, Chief Legal Officer of Sorrento Therapeutics, led the roundtable discussion among experienced in-house counsel. The roundtable discussion provided an open dialogue around ideas and opportunities to improve the process for completing technology and IP licenses.
Ms. Watson heads the Mergers and Acquisitions, Securities and Corporate Team in Southern California and leads the Corporate Department's Southern California Chemical & Life Sciences and Medical Devices Teams. She has extensive experience representing companies, corporate boards and executives in complex transactions, in numerous industries, with an emphasis on healthcare and pharmaceutical, internet and media, biomedical, software and technology, oil and gas-petrochemicals and food and beverage companies. Ms. Watson is the Sponsor Chair of ACC San Diego’s Technology/Licensing Practice Committee.
Follow the firm on Twitter: @KTS_Law.
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.